Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MANUFACTURER SHIPMENTS OF NON-BARBITURATE SEDATIVES/NARCOTICS JUMP 78% IN 1985 TO $120.9 MIL., CENSUS BUREAU REPORTS; ALL DRUGS UP 10% TO $22 BIL.

Executive Summary

The value of manufacturer shipments of ethical, non-barbiturate sedatives and narcotics increased 78% to $120.9 mil. between 1984 and 1985, according to figures published by the U.S. Department of Commerce, Bureau of the Census, in its most recent industrial report for the pharmaceutical industry. Shipments of barbiturates stablized during the period at approximately $23 mil. However, growth in shipments of central nervous system drugs overall increased 14% to $5.7 bil., the Census Bureau reported. The central nervous system category continues to be by far the largest segment in the Census Bureau breakdown of the drug industry, almost 70% larger than the next largest category of antiparasitics and anti-infectives. An increase in total sedative and hypnotic shipments during 1985, combined with a leveling of barbiturate shipments suggest the continuing growth in 1985 of the benzodiazepine class. The fasting growing class in 1985 was the respiratory drug group. Total ship values jumped almost 22% to over $2.2 bil. Cardiovasculars grew 17% in 1985 and have increased in value of shipments almost 300% since 1978. In total, manufacturer shipments of ethical and OTC pharmaceutical preparations, with the exception of biologicals, amounted to $23.4 bil. in 1985, according to the Bureau of Census data, an increase of 10% over $21.1 bil. in 1984. Of this total, human pharmaceuticals made up 94% or $21.1 bil., up 11% over 1984, the agency noted. Shipments of veterinary products declined 3% to $818.1 mil. [Editor's Note: The value of shipments is defined as the net sales price of physcial shipments of all products sold, transferred to other establishments of the same company, or shipped on consignment, whether for domestic or export sale.] Chart omitted.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS010999

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel